GNGB.Y Stock Overview Provides products and solutions for operating rooms, intensive-care units, and sterilization departments. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Getinge AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Getinge Historical stock prices Current Share Price SEK 16.18 52 Week High SEK 22.85 52 Week Low SEK 14.84 Beta 0.49 1 Month Change 6.72% 3 Month Change -28.95% 1 Year Change -27.84% 3 Year Change -62.88% 5 Year Change -13.09% Change since IPO -57.43%
Recent News & Updates Getinge AB (publ) to Report Q1, 2025 Results on Apr 22, 2025
Getinge AB (Publ) Announces Changes of the Nomination Committee Nov 28
Getinge Appoints Alexandra Holland Executive Vice President of Communications, Effective November 11, 2024 Nov 08
Getinge AB (publ) (OM:GETI B) completed the acquisition of Paragonix Technologies, Inc. from Signet Healthcare Partners. Sep 13
Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire Paragonix Technologies, Inc. from Signet Healthcare Partners for approximately $480 million. Aug 23
Getinge AB (publ) to Report Q2, 2024 Results on Jul 18, 2024 Jul 01 See more updates Getinge AB (publ) to Report Q1, 2025 Results on Apr 22, 2025
Getinge AB (Publ) Announces Changes of the Nomination Committee Nov 28
Getinge Appoints Alexandra Holland Executive Vice President of Communications, Effective November 11, 2024 Nov 08
Getinge AB (publ) (OM:GETI B) completed the acquisition of Paragonix Technologies, Inc. from Signet Healthcare Partners. Sep 13
Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire Paragonix Technologies, Inc. from Signet Healthcare Partners for approximately $480 million. Aug 23
Getinge AB (publ) to Report Q2, 2024 Results on Jul 18, 2024 Jul 01
Getinge AB (publ) Declares A Dividend, Payable on 29 April 2024 Apr 23 Getinge AB (publ) to Report Fiscal Year 2024 Results on Jan 28, 2025 Getinge AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024 Getinge AB (Publ) Proposes Dividend, Payable on April 29, 2024
Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3 Mar 08 Getinge AB (Publ) Provides Sales Guidance for the Year 2024 Getinge Announces CFO Changes Jan 23
Getinge AB (publ) (OM:GETI B) acquired Healthmark Industries Company, Inc. for $320 million. Oct 12
Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023 Sep 20
Getinge Receives US FDA 510(K) Clearance for Servo-Air® Lite Jul 08
Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million. Jun 01
Getinge Provides Financial Guidance for the First Half, Second Half and Full Year of 2023 Feb 03
Getinge AB (Publ) Proposes Dividend Feb 02
U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes Its Subsidiary Datascope Nov 22
Getinge AB (publ) Provides Sales Guidance for the Full Year 2022 Oct 19
Getinge AB (Publ) Announces Executive Changes Oct 14
Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team Sep 24
Getinge AB (Publ) Announces Medical Device Field Action of Hls Set Advanced Products Jul 20
Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team Jul 15
Getinge AB (publ) to Report Q2, 2022 Results on Jul 19, 2022 Jul 05 Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs Jul 01
Getinge Revises Net Sales Guidance for the Full Year 2022 Jun 15
Getinge AB (publ) Declares Dividend for 2021, Payable on May 3, 2022 Apr 27
Getinge AB (publ) to Report Q1, 2022 Results on Apr 26, 2022 Apr 09 Getinge AB to Report Q4, 2022 Results on Feb 01, 2023 Getinge AB to Report Q4, 2022 Results on Feb 01, 2023
Getinge AB (OM:GETI B) acquired Talis Clinical, LLC for approximately SEK 600 million. Dec 24
Getinge AB Provides Sales Guidance for the Year 2021 Jul 16
Getinge's New Torin Artificial Intelligence Solution Improves Hospital Efficiency Jun 11
Getinge AB Proposes Dividend, Payable on April 27, 2021 Mar 16
Getinge AB and University of Gothenburg Initiates Strategic Research Partnership Feb 18
Getinge AB Proposes Executive Changes Feb 05
Getinge Is Announcing A Recall of HLS Set Advanced Products Nov 11
Getinge AB Provides No Guidance for the Fourth Quarter of 2020 and for Year 2021 Oct 18
Getinge Not to Present Outlook for the Full Year 2020 Oct 16
Getinge Announces Ventilation Technology for Both Premature Babies and Adults Oct 04
Getinge AB to Report Q3, 2020 Results on Oct 16, 2020 Oct 02
Getinge Announces Voluntary Recall of the Servo-i Ventilator System's Nebulizer Connector Sep 24
Getinge AB Appoints Anna Romberg as Executive Vice President Legal, Compliance & Governance and Member, with Effect from October 01, 2020 Sep 17 Shareholder Returns GNGB.Y US Medical Equipment US Market 7D 1.7% -1.2% -2.7% 1Y -27.8% 10.0% 23.4%
See full shareholder returns
Return vs Market: GNGB.Y underperformed the US Market which returned 23.4% over the past year.
Price Volatility Is GNGB.Y's price volatile compared to industry and market? GNGB.Y volatility GNGB.Y Average Weekly Movement 4.1% Medical Equipment Industry Average Movement 7.7% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.9% 10% least volatile stocks in US Market 3.2%
Stable Share Price: GNGB.Y has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: GNGB.Y's weekly volatility (4%) has been stable over the past year.
About the Company Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Show more Getinge AB (publ) Fundamentals Summary How do Getinge's earnings and revenue compare to its market cap? GNGB.Y fundamental statistics Market cap US$4.40b Earnings (TTM ) US$153.08m Revenue (TTM ) US$3.04b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) GNGB.Y income statement (TTM ) Revenue SEK 33.59b Cost of Revenue SEK 18.21b Gross Profit SEK 15.39b Other Expenses SEK 13.69b Earnings SEK 1.69b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
Earnings per share (EPS) 6.21 Gross Margin 45.80% Net Profit Margin 5.03% Debt/Equity Ratio 30.0%
How did GNGB.Y perform over the long term?
See historical performance and comparison Dividends
2.5% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 02:06 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Getinge AB (publ) is covered by 34 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Sten Gustafsson ABG Sundal Collier Kamla Singh AlphaValue Scott Bardo Berenberg
Show 31 more analysts 
